Search

AVAC Infographics for CROI 2026

Going to CROI? AVAC’s up-to-date infographics — on the research & development pipeline, prevention options, and the impact of US funding cuts — are available here for use in conference presentations. We constantly update these graphics, so check back for updates. The latest version of the deck will be available here.

HIV Vaccine Clinical Trials Pipeline

This graphic summarizes the state of HIV vaccine research, detailing the different immunological approaches in clinical trials, the specific candidates being studied, and the collaborative networks of funders and developers working toward an effective vaccine.

Global Health Watch: States Sue Over Public Health Funding, Vaccine Systems Strain, Advocates Press Merck on Equitable Access

It’s been one year since AVAC and the Global Health Council filed their lawsuits over the sweeping foreign assistance freeze — cases that challenged the Administration’s withholding of Congressionally appropriated funds. That broader dispute continues, as four US states sued the administration over its decision to withhold $600 million in public health grants. This issue also examines ongoing signs of erosion in vaccine confidence and calls for early global access planning for Merck’s monthly oral PrEP candidate.

CROI 2026 Community Breakfast Meetings

Lenacapavir Regulatory Approval

Regulatory approvals, pending decisions, and appeals as of February 2026.

One year ago, we sued the US Government…

On the first day of the new administration, a sweeping foreign aid freeze shut down life-saving HIV and global health programs overnight. Over 52 weeks, AVAC documented the harm, and took the fight to court.

Global Health Watch: Foreign Affairs Bill Passes, Aid Cuts Projected to Cause Millions of Deaths by 2030, UN & WHO in Financial Crisis

This week a $50 billion US foreign affairs spending bill was signed into law, averting severe proposed cuts; a new modelling analysis projects millions of additional preventable deaths by 2030 if global aid cuts continue; and the financial crises facing the UN and WHO continue. We are also following plans to transition or close the Oregon National Primate Research Center, a leading research institution.

Impact of US Withdrawal from WHO, New Data on PrEP, Cure Academy Applications Open

New this week: resources on the impact of harmful US policies on the HIV response; updated infographics on the ups and downs in PrEP; and an opportunity to apply for the US HIV Cure Academy in North Carolina this April.

Dapivirine Ring: Giving Women Hope and Choice in HIV Prevention

Source of Lenacapavir for PrEP Supply to Early Adopter Countries

The Global Fund, with support from CIFF, and PEPFAR have jointly committed to reaching up to two million people with injectable lenacapavir for PrEP over three years. Supply of LEN began arriving in countries in late 2025 with service delivery planned to start in early 2026.